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ABSTRACT The pathogenic species of Cryptococcus are a major cause of mortality
owing to severe infections in immunocompromised as well as immunocompetent in-
dividuals. Although antifungal treatment is usually effective, many patients relapse
after treatment, and in such cases, comparative analyses of the genomes of incident
and relapse isolates may reveal evidence of determinative, microevolutionary changes
within the host. Here, we analyzed serial isolates cultured from cerebrospinal fluid
specimens of 18 South African patients with recurrent cryptococcal meningitis. The
time between collection of the incident isolates and collection of the relapse isolates
ranged from 124 days to 290 days, and the analyses revealed that, during this pe-
riod within the patients, the isolates underwent several genetic and phenotypic
changes. Considering the vast genetic diversity of cryptococcal isolates in sub-
Saharan Africa, it was not surprising to find that the relapse isolates had acquired
different genetic and correlative phenotypic changes. They exhibited various mecha-
nisms for enhancing virulence, such as growth at 39°C, adaptation to stress, and
capsule production; a remarkable amplification of ERG11 at the native and unlinked
locus may provide stable resistance to fluconazole. Our data provide a deeper un-
derstanding of the microevolution of Cryptococcus species under pressure from anti-
fungal chemotherapy and host immune responses. This investigation clearly sug-
gests a promising strategy to identify novel targets for improved diagnosis, therapy,
and prognosis.
IMPORTANCE Opportunistic infections caused by species of the pathogenic yeast
Cryptococcus lead to chronic meningoencephalitis and continue to ravage thousands
of patients with HIV/AIDS. Despite receiving antifungal treatment, over 10% of pa-
tients develop recurrent disease. In this study, we collected isolates of Cryptococcus
from cerebrospinal fluid specimens of 18 patients at the time of their diagnosis and
when they relapsed several months later. We then sequenced and compared the
genomic DNAs of each pair of initial and relapse isolates. We also tested the isolates
for several key properties related to cryptococcal virulence as well as for their sus-
ceptibility to the antifungal drug fluconazole. These analyses revealed that the re-
lapsing isolates manifested multiple genetic and chromosomal changes that affected
a variety of genes implicated in the pathogenicity of Cryptococcus or resistance to
fluconazole. This application of comparative genomics to serial clinical isolates pro-
Received 2 February 2017 Accepted 6
February 2017 Published 7 March 2017
Citation Chen Y, Farrer RA, Giamberardino C,
Sakthikumar S, Jones A, Yang T, Tenor JL, Wagih
O, Van Wyk M, Govender NP, Mitchell TG,
Litvintseva AP, Cuomo CA, Perfect JR. 2017.
Microevolution of serial clinical isolates of
Cryptococcus neoformans var. grubii and
C. gattii.mBio 8:e00166-17. https://doi.org/
10.1128/mBio.00166-17.
Editor Françoise Dromer, Institut Pasteur
Copyright © 2017 Chen et al. This is an open-
access article distributed under the terms of
the Creative Commons Attribution 4.0
International license.
Address correspondence to Christina A.
Cuomo, cuomo@broadinstitute.org, or John R.
Perfect, john.perfect@dm.duke.edu.
* Present address: Yuan Chen, Aperiomics, Inc.,
Ashburn, Virginia, USA.
This article is a direct contribution from a
Fellow of the American Academy of
Microbiology. External solicited reviewers:
James Kronstad, University of British Columbia;
Peter Williamson, National Institutes of Health.
RESEARCH ARTICLE
crossm
March/April 2017 Volume 8 Issue 2 e00166-17 ® mbio.asm.org 1
 
m
bio.asm
.org
 o
n
 M
arch 8, 2017 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
vides a blueprint for identifying the mechanisms whereby pathogenic microbes
adapt within patients to prolong disease.
Pathogenic species of Cryptococcus are encapsulated yeasts that normally reside inthe environment, where they readily become airborne and can infect humans
through inhalation. These yeasts are neurotropic; after causing pulmonary infection,
they can spread to the central nervous system (CNS) and cause life-threatening
meningoencephalitis. Cryptococcal species have evolved manifold attributes that en-
able them to progress from latent infection to disease in immunocompetent individuals
as well as in patients with suppressed cellular immunity, especially those with HIV/AIDS
(1–4). Many of the human risks for increased susceptibility to cryptococcal disease have
been determined. With regard to the pathogen, basic research has shown that the
Cryptococcus genome is dynamic in its plasticity (5), but little is known about the
genetic and phenotypic adaptations that the yeast cells undergo to invade, survive, and
proliferate in the CNS of patients. To directly examine the properties of cryptococcal
cells during this critical process, our previous study profiled the expression of Crypto-
coccus genes at the site of human meningitis. In that study, genes related to catalytic
activity and transporters, such as ENA1 and CFO1, were significantly upregulated in
cerebrospinal fluid (CSF) during infection, suggesting the importance of such functions
for survival of the yeasts in the harsh human environment, specifically within the
subarachnoid space (6, 7). Although these studies identified expression signatures
during active infection, they provided only an initial glimpse of how this yeast is able
to adapt rapidly and continuously to assault by host immune responses and treatment
with antifungal drugs.
An independent approach to look at adaptation is to examine mutations that occur
over the course of an infection and determine if any confer a selective advantage in the
host. Between 10% and 20% of HIV/AIDS patients in South Africa develop recurrent
cryptococcal meningitis (8). Consequently, genetic and phenotypic dissection of clinical
relapse isolates may elucidate how the initial infecting isolate adapted to the CNS of the
host. Microevolution of isolates of Cryptococcus has been documented in several cases
of recurrent infection as well as by in vitro and in vivo experiments (9–11). In a recent
report of a case of recurrent cryptococcal meningoencephalitis (CM), the genomic
sequences of incident and relapse isolates were compared after 77 days in the patient’s
CNS (12). Several mutations were identified between these serial isolates, and a
frameshift mutation in the AT-rich interaction domain-containing (ARID) transcriptional
regulator was implicated in several phenotypic differences, including reduced capsule
size and altered carbon source preference. In addition, strains with higher rates of
spontaneous mutation may display accelerated microevolution within the host (11),
and the serial passage of cryptococcal strains in the same host can change their
virulence potential (13). These studies clearly indicated the importance of microevolu-
tion in the adaptation of Cryptococcus to the human CNS and ability to cause disease.
In an earlier investigation, we examined the incident and relapse isolates of 81
HIV/AIDS patients from South Africa with recurrent cryptococcal meningoencephalitis
(14). Each isolate was genotyped by multilocus sequence typing (MLST). As expected
from previous studies, the vast majority of cases were caused by isolates of C. neofor-
mans var. grubii, which consists of three distinct molecular types, VNI, VNII, and VNB (15,
16). Infections with C. gattii are less common in South Africa and are caused by
molecular type VGI or VGIV (17). After initial diagnosis and treatment with fluconazole
(FLZ) and/or amphotericin B (AMB), in most cases, recurrent disease can ensue because
of reinfection with a different isolate or persistent infection by the initial isolate and
relapse, perhaps due to inadequate antifungal treatment or selection of the more
virulent clones within the patient. In this cohort, 89% of relapse episodes were caused
by isolates with the same genotype(s) as the incident isolates (14).
To investigate the microevolution of C. neoformans var. grubii and C. gattii in the CNS
under selective pressure from the host immune responses and antifungal treatment, we
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analyzed the incident and relapse isolates from 18 patients. These serial isolates
appeared clonal based on MLST analysis (14). Using whole-genome sequencing, we
traced the mutational events of each isolate during its passage in the patient and
compared these mutations to key phenotypic changes in the same isolates. Correlative
changes in genotype and phenotype were detected during in vivo microevolution, and
multiple genes were implicated in shifts toward resistance to FLZ or adaptation to the
host.
RESULTS
Whole-genome sequencing of serial isolates. This investigation included 32
isolates of C. neoformans var. grubii and six C. gattii isolates (see Table S1 in the
supplemental material). Each incident isolate was cultured from a specimen of CSF at
the diagnosis of cryptococcal meningoencephalitis but prior to treatment. Relapse
isolates were obtained from subsequent CSF specimens more than 120 days following
collection of the incident isolate.
Genome-wide variants were identified for each isolate and compared to examine
changes during passage. Genomic DNA of each isolate was extracted from a single
colony and analyzed by aligning Illumina reads to their most closely related reference
assemblies, allowing the identification of single nucleotide polymorphisms (SNPs) and
indels (insertion or deletion events; see Materials and Methods). High-depth (268 on
average) read alignments covered over 96% of the reference genome nucleotides for
most isolates (Fig. 1; see also Fig. S1 and Table S2 in the supplemental material).
Stringent filters were applied to SNP calls to reduce false positives, such as near-
alignment errors due to adjacent indels, and the final calls were manually validated. To
verify the data and check for clonality of serial isolates, a phylogenetic tree of C. neo-
1 2 3 4 5 6 7 8   9   10   11   12   13   14
FIG 1 Aneuploid regions of all C. neoformans var. grubii isolates. For each sequenced isolate, the normalized read depth is shown in 5-kb windows along each
chromosome relative to the H99 reference, and average normalized depth on the y axis is relative to ploidy levels.
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formans var. grubii isolates was inferred from the SNPs for each strain (Fig. 2A). This
phylogeny confirmed that each patient’s isolates were closely related, suggesting
clonality, and concordant with the previous MLST study (14). The patient isolates were
comprised of diverse molecular types. The C. neoformans var. grubii cases included
eight with molecular type VNI, five with molecular type VNII, and two with molecular
type VNB; the C. gattii cases included one with molecular type VGI and two with
molecular type VGIV.
SNP calling and comparisons between the serial isolates. To investigate micro-
evolution during infection, we more closely compared the single nucleotide polymor-
phism (SNPs) between the isolates from each patient (Table 1). The number of SNPs
between incident and relapse pairs ranged from zero (cases 76 and 91) to six (case 1);
between the first and second relapse isolates, two and four SNPs were identified (cases
15 and 77, respectively). In total, 43 SNP sites were identified among all the paired
C. neoformans var. grubii isolates. Five SNPs were identified in the two VGIV serial
isolates (Table S3), and no SNP was found between the two serial isolates of VGI.
Among the C. neoformans var. grubii isolates, 29 of the 43 SNPs were located within the
coding regions of 26 different genes. Remarkably, more than two-thirds (20/29) of these
changes resulted in nonsynonymous mutations distributed among 19 genes, and 5
introduced stop codons. For C. gattii isolates, three of the five SNPs between VGIV
isolates were in coding regions, and two SNPs resulted in nonsynonymous mutations
(Table S4). For cases 15 and 77 of C. neoformans var. grubii, which had second relapse
isolates, only half of the SNPs detected between the first and second relapses were
retained in the second relapse isolate. Although samples from only two patients were
studied here, these findings suggest that perhaps half the mutations that occur during
a similar time span of cryptococcal infection are transient or not fixed in the population,
which has also been suggested in previous studies in both Candida albicans and
Mycobacterium tuberculosis (18, 19).
Some of the affected genes are reported to encode potential virulence factors or to
be involved in stress responses or are potentially important for fitness and survival
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FIG 2 Phylogenetic relationships of the serial isolates and comparison of duplicated genomic regions in six relapse isolates. (A) Phylogenetic tree inferred by
using RAxML from 503,457 SNPs in the C. neoformans var. grubii genome (2.7% of the genome). A total of 1,000 bootstrap replicates were performed, and nodes
with 100% bootstrap support are denoted by asterisks (*). (B) Copy number of three C. neoformans var. grubii chromosomes (chromosomes 2, 5, and 12) for
six isolates with a large genomic duplication; orange regions show elevated copy numbers, and regions with normal copy number are shown in green.
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within the host. For example, Crz1 (Sp1; CNAG_00156) is a transcription factor activated
by calcineurin and regulates cell wall integrity (20). We identified a null mutation of this
gene in the incident isolate of case 9 (RSA-MW-2364), and this site reverted in the
corresponding relapse isolate (RSA-MW-3580) to produce a functional copy of this
gene. In addition to inactivating mutations, nonsynonymous changes were detected in
several important genes. Eukaryotic initiation factor 2 alpha (eIF2A; CNAG_05366)
mediates stress responses, and this function has been conserved across different
species (21–24). MCM2 (CNAG_03341) is a member of the minichromosome mainte-
nance (MCM) protein family that is highly conserved throughout evolution and essen-
tial for eukaryotic DNA replication (25, 26); in Saccharomyces cerevisiae, this gene also
responds to ethanol stress (24, 27). The protein kinase CTK1 (CNAG_04118) was
identified in a large-scale screen for genes required for virulence (28).
Small insertions/deletions (indels) identified in the serial isolates. In addition to
SNPs, indels were detected between incident and relapse isolates. Each candidate indel
within a coding region was manually examined for read support, resulting in six short
indels verified from five pairs of incident and relapse isolates (Table 1). Each of these six
indels caused frame shifts in the corresponding coding regions. Five indels involved the
insertion or deletion of one or two nucleotides, and the sixth was a deletion of 25
nucleotides in the relapse isolate. Two of these changes were present only in the initial
isolates and reverted in the relapse isolates (from patients 15 and 81) compared to the
reference genome (Table 2). Among these genes, the gene encoding the eIF2A kinase,
GCN2 (CNAG_06174), may be involved in several stress responses (29, 30), and the RPD3
(CNAG_05690) gene encodes histone deacetylase and is a repressor that regulates a
large number of genes (31). A frameshift due to the insertion of a single base was
detected in MLH3 (CNAG_01037), encoding an endonuclease involved in DNA mis-
match repair (32) that was recently identified in a screen for genes required for
C. neoformans var. grubii virulence in three experimental infection models (33).
Variation in copy number was discovered in several genes and genomic
regions. In addition to SNPs and small indels, the comparison of genomic sequences
between serial isolates revealed large stretches that differed in copy number. The
relapse isolate of patient 8 (RSA-MW-3393) acquired a large deletion of a region on
chromosome 3 (chr3) from nucleotide 1303709 to nucleotide 1319672 (~16 kb). Six
TABLE 1 Numbers of SNPs, small indels, and large deletions between the incident and
relapse isolates or between the first-relapse and second-relapse isolates (case 15R and
case 17R)
Case IDa
Molecular
type
No. of
NPs
No. of
small indels
No. of large
deletions
1 VNI 6 1 0
8 VNI 1 0 1
14 VNI 1 0 0
15 VNI 2 1 0
15R VNI 2 0 0
22 VNI 1 1 0
76 VNI 0 0 0
82 VNI 1 0 0
87 VNI 4 0 0
7 VNB 2 0 0
81 VNB 5 2 0
5 VNII 1 0 0
9 VNII 2 0 0
45 VNII 4 0 0
77 VNII 6 0 0
77R VNII 4 0 0
90 VNII 5 0 0
91 VGI 0 0 0
31 VGIV 4 1 0
67 VGIV 1 0 0
aID, identifier.
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genes are located in this region, including an oxygenase (CNAG_02580), Cas33 lipase
(CNAG_02581), a methyltransferase (CNAG_02583), and an ARID domain protein
(CNAG_02579). A recent study of one pair of serial isolates found a single mutation of
the ARID domain protein that may contribute to multiple phenotypic changes (12).
Another large duplication region was observed on chromosome 5 from nucleotide
791401 to nucleotide 876600 (85.2 kb) of the incident isolate from patient 8 (RSA-MW-
1340), with 28 genes duplicated in this region (Fig. 2B; Table 3). Of these genes,
deletions of SET101 (CNAG_01243) and UFD4 (CNAG_01251) were shown to attenuate
the virulence of C. neoformans var. grubii in mice; SET101 was also related to melanin
production (28). CDA2 (CNAG_01230) and CDA3 (CNAG_01239) encode two of the three
deacetylases that account for the production of chitosan, which is necessary for
maintenance of the cryptococcal cell wall and capsule (34). PMC1 (CNAG_01232)
encodes a calcium transporter, which provides Ca2 tolerance and is essential for the
progression of pulmonary infection in mice and dissemination to the brain (35). HapX
(CNAG_01242) regulates iron acquisition and metabolism (36), and a recent study of the
other iron acquisition gene, FRE3, showed that this type of gene can be viewed as a
“virulence adaptation gene” and evolved in mammalian hosts (37).
By closer examination of the genes within the deletion and duplication genomic
regions, we detected six genes with more than two copies in the relapse isolates of four
patients (Table 3). Four of the six genes were functionally unknown, and the other two
genes were ERG11 (CNAG_00040) and CRG2 (CNAG_01371). ERG11 encodes the FLZ
target enzyme, sterol 14-demethylase (38). Crg2 is a regulator of G-protein signaling
homologs, and the null mutant of CRG2 has been shown to attenuate virulence in mice
(39). In the relapse isolate from patient 9, the copy number of a small region of
chromosome 1 that includes three genes (CNAG_00039, ERG11, and CNAG_07308) was
dramatically increased. Two copies were present in the incident isolate (RSA-MW-1746)
and 13 copies in the relapse isolate (RSA-MW-3615). This remarkable amplification of
ERG11 was likely selected following treatment of this patient with FLZ.
The apparent plasticity of the cryptococcal genome allows frequent duplication of
chromosomes in vivo (40, 41). In our study, we identified a partial duplication of
chromosome 2 from around nucleotide 945000 to the end of the chromosome in all
three isolates from patient 15 and duplication of chromosome 12 in the incident isolate
from patient 45 and the relapse isolate from patient 81 (Fig. 2B). Neither chromosome
2 nor chromosome 12 duplications is known to confer increased drug resistance;
however, they may provide other selective advantages or may simply result from
genomic instability during infection.
Higher resistance to fluconazole in the relapse isolates. Since 16 of the 18
patients in this study were treated with antifungal drugs (Table S1), we sought to
examine the level of drug resistance in each relapse isolate. Two patients, cases 45 and
90, lacked a record of receiving antifungal treatment (14). Three patients (cases 1, 22,
and 90) were treated with both AMB and FLZ, and seven patients received either AMB
TABLE 2 Comparison of small indels that differed between paired serial isolatesa
CHR POS
Reference (H99)
nucleotide(s) ALT
Indel result for case:
Gene ID Name Description1 15 22 81 87
5 1378568 C CT 0–1 CNAG_01037 MLH3 DNA mismatch repair
protein MLH3
7 623649 TC T 0–1 CNAG_05690 RPD304 Histone deacetylase RPD3
10 405507 GCTTCCGCTTCCGCTG
CACGACCGAGT
G 0–1 CNAG_04786 Hypothetical protein
12 126473 AT A 0–1a CNAG_06033 pfkB family carbohydrate
kinase superfamily
12 520033 CCT C 1–0 CNAG_06174 GCN2 Pek/GCN2 protein kinase
13 195919 TC T 1–0 CNAG_06325 BYR4 GTPase activator
a“0–1” and “1–0” denote the gain and loss, respectively, of a small indel between initial and relapse isolates of the indicated cases. “0” represents a base(s) identical
to that in the reference genome (H99), and “1” indicates the alternative (ALT) sequence. CHR, chromosome; POS, position.
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or FLZ (Table S1). By the use of the CLSI broth microdilution method to determine MICs,
each isolate was tested for susceptibility to FLZ. In total, five relapse isolates had 4-fold
or greater FLZ MICs than the corresponding incident isolates (Table 4 and S6). Among
all the isolates, the relapse isolate (RSA-MW-3615) from patient 9 had the highest FLZ
TABLE 3 Genes that differed in copy number between serial isolatesa
Gene ID
Gene
name Description of product CHR Case 8 Case 22 Case 5 Case 77 Case 81 Case 82 Case 9
CNAG_02579 ARID domain protein 3 1.00 ¡ 0
CNAG_02580 2OG-Fe(II) oxygenase
superfamily domain
3 1.00 ¡ 0
CNAG_02581 CAS33 CAS33 capsule-associated
protein
3 1.00 ¡ 0
CNAG_02582 Hypothetical protein 3 1.00 ¡ 0
CNAG_02583 tRNA (guanine10-N2)-
methyltransferase
3 1.00 ¡ 0
CNAG_02584 Serine/threonine-protein
phosphatase 2A
activator 1
3 1.00 ¡ 0
CNAG_07981 Hypothetical protein 5 1.91 ¡ 1.00
CNAG_01229 L-Mandelate
dehydrogenase
5 1.91 ¡ 1.00
CNAG_01230 Cda2 Chitin deacetylase 5 1.91 ¡ 1.00
CNAG_01231 Agmatinase 5 1.91 ¡ 1.00
CNAG_01232 PMC1 Putative calcium-
transporting ATPase
5 1.91 ¡ 1.00
CNAG_01233 Hypothetical protein 5 1.91 ¡ 1.00
CNAG_01234 Spore wall assembly-
associated protein
5 1.91 ¡ 1.00
CNAG_01235 DNA-directed RNA
polymerase II subunit
RPB2
5 1.91 ¡ 1.00
CNAG_01236 rRNA-processing protein
EBP2
5 1.91 ¡ 1.00
CNAG_01237 Hypothetical protein 5 1.91 ¡ 1.00
CNAG_01238 Arginine biosynthesis
ArgJ, mitochondrial
5 1.91 ¡ 1.00
CNAG_01239 Cda3 Chitin deacetylase 5 1.91 ¡ 1.00
CNAG_01240 Hypothetical protein 5 1.91 ¡ 1.00
CNAG_01241 Enzyme regulator 5 1.91 ¡ 1.00
CNAG_01242 HapX bZIP transcription factor 5 1.91 ¡ 1.00
CNAG_01243 SET101 Histone-lysine N-
methyltransferase, H3
lysine-4 specific
5 1.91 ¡ 1.00
CNAG_01244 Hypothetical protein,
hypothetical protein,
variant
5 1.91 ¡ 1.00
CNAG_01245 Hypothetical protein 5 1.91 ¡ 1.00
CNAG_01246 Hypothetical protein 5 1.91 ¡ 1.00
CNAG_01247 Hypothetical protein 5 1.91 ¡ 1.00
CNAG_01248 Vacuole morphology and
inheritance protein 14
5 1.91 ¡ 1.00
CNAG_01249 Hypothetical protein 5 1.91 ¡ 1.00
CNAG_01250 tRNA ligase 5 1.91 ¡ 1.00
CNAG_01251 UFD4 e3 ubiquitin-protein ligase 5 1.91 ¡ 1.00
CNAG_01252 Thiosulfate/3-
mercaptopyruvate
sulfurtransferase
5 1.91 ¡ 1.00
CNAG_01253 Mitochondrial import
inner membrane
translocase subunit
TIM10
5 1.91 ¡ 1.00
CNAG_01254 Protein-tyrosine-
phosphatase
5 1.91 ¡ 1.00
CNAG_01255 Hypothetical protein 5 1.91 ¡ 1.00
CNAG_07876 Hypothetical protein 14 1.00 ¡ 1.90 1.00 ¡ 2.00 1.96 ¡ 1.00 1.00 ¡ 1.86 1.84 ¡ 1.00
CNAG_01370 Hypothetical protein 5 1.00 ¡ 2.00
CNAG_01371 CRG2 Regulator of G protein
signaling
5 1.00 ¡ 2.00
CNAG_00039 Hypothetical protein 1 1.00 ¡ 12.99
CNAG_07308 Hypothetical protein 1 2.06 ¡ 12.99
CNAG_00040 ERG11 Lanosterol
14-alpha-demethylase
1 2.06 ¡ 12.99
aIn the columns below each case number, the first number indicates the number of copies of the listed gene in the initial isolate, and the second number indicates
the number of copies in the relapse isolate.
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MIC (128 g/ml), 16-fold greater than the MIC seen with the incident isolate (RSA-MW-
1746; MIC, 8 g/ml). Two genes, BYR4 (CNAG_06325) and ERG11, were associated with
increased resistance to FLZ in case 15 and case 9, respectively. A single base deletion
was identified in BYR4 for the incident isolate from patient 15, but this change reverted
in the relapse isolate (Table 2). Byr4 is a dosage-dependent regulator of cytokinesis (42),
and it has been reported to be essential for resistance of C. neoformans var. grubii to FLZ
(43). The deletion of the nucleotide caused a frameshift affecting two-thirds of the
protein length, likely to produce a loss of Bry4 function. Therefore, the changes in FLZ
resistance in case 15 serial isolates might be directly associated with this mutation.
The duplication of genes and genomic regions is another well-documented mech-
anism for developing resistance to FLZ. In fact, heteroresistance in Cryptococcus has
been described and shown to be due to aneuploidy, with duplication of chromosome
1 containing the gene (AFR1) encoding an efflux pump and the target (ERG11) of FLZ
(44). This duplication can be observed in vivo when the yeast is under stress, but the
extra copy is lost under nonstress growth conditions (40). Therefore, our sequencing of
a single colony after many passages in vitro may have missed some changes in
chromosomal aneuploidy. Furthermore, we observed no changes or duplication in the
AFR1 gene between any paired isolates. In case 9, an alternative yeast strategy of
resistance was used. The increased MIC of the relapse isolate can be attributed to the
extensive local duplication of ERG11 and elevated production of Erg11, the target of
FLZ. Indeed, the copy number of this small genomic region increased from 2 in the
incident isolate to 13 in the relapse isolate (Table 3). By more finely mapping the read
coverage boundaries of the duplicated regions in the two genomes, we found that the
duplicated region on chromosome 1 of the incident isolate (from nucleotide 123657 to
nucleotide 128150) was smaller than in the relapse isolate (from nucleotide 121438 to
nucleotide 129598), suggesting that multiple independent amplifications can contrib-
ute to resistance (Fig. 3A). Previous studies reported that increasing the copy number
of ERG11 or the related region can produce resistance to FLZ in C. neoformans var. grubii
(40). However, to the best of our knowledge, this is the first observation that C. neo-
formans var. grubii can so markedly amplify ERG11.
TABLE 4 Serial isolates with more than two significant phenotypic changes (more than
4 FLZ resistance changes or other tests with P value less than 0.05)
Phenotypic test Type
Phenotypic test results for case:
7 8 9 15 45 77 81
MIC (g/ml) Incident 1 4 8 2 1 2 4
Relapse 16 8 128 8 8 4 64
37°C YPD Incident 1.739a 0.748 1.614 1.736 1.515 1.535 1.744
Relapse 1.859 1.854 1.332 1.857 1.543 1.715 1.832
P value 0.015
39°C YPD Incident 0.604 0 1.673 1.738 0.141 0.459 1.713
Relapse 0 1.015 0.043 1.702 0.518 1.820 0.592
P value 0.001 0.035 0.011 0.004
YPD  0.03% SDS Incident 1.810 0.671 1.885 0 3.413 0 2.350
Relapse 2.069 1.693 1.837 1.702 3.324 2.197 2.642
P value 0.007 0.004
YPD  0.5 g/liter
caffeine
Incident 1.077 1.261 0.970 1.997 1.516 0.014 1.216
Relapse 1.158 1.535 0.872 1.398 0.911 1.069 2.836
P value 0.003
YPD  100 mg/liter
L-DOPA
Incident 0.278 0.245 0.173 0.364 0.546 0.468 0.152
Relapse 0.271 0.478 0.184 0.292 0.471 0.475 0.318
P value 0.045 0.037
aThe normalized mean values (other than MIC values and P values) from three independent tests (see
Materials and Methods).
Chen et al. ®
March/April 2017 Volume 8 Issue 2 e00166-17 mbio.asm.org 8
 
m
bio.asm
.org
 o
n
 M
arch 8, 2017 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
Investigating mechanisms of ERG11 amplification. To investigate the underlying
duplication mechanism of this small region, we mapped the surrounding regions using
a Tagmentation-based mapping (TagMap) assay (45) on both isolates of case 9. Specific
primers were designed adjacent to the break points of the duplications (Fig. 3B), and
the duplicated and flanking sequences were amplified and sequenced (Materials and
Methods). This sequencing mapped the two copies of this region in RSA-MW-1746 to
two different chromosomes. One copy was found on chromosome 1, the typical locus
in all isolates, and the second copy was located on chromosome 6, replacing the
original sequence from nucleotide 991188 to nucleotide 991395 in the 3=-to-5= direc-
tion compared to the H99 reference genome (Fig. 3C). The same repetitive element was
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FIG 3 Analyses of the highly amplified genomic sequences containing ERG11 in the isolates from patient 9. (A) The region of chromosome 1 (Chr1) that includes
the ERG11 gene (CNAG_00040) was duplicated on Chr6. Two copies of this region on Chr1 from nucleotide 123675 to nucleotide 128150 were identified in
the incident isolate (RSA-MW-1746), and the extra copy was mapped as an insertion into Chr6. A larger duplicated region was identified in the relapse isolate
(RSA-MW-3615) with an average of 13 coverage on chromosome 1 from nucleotide 121438 to nucleotide 129598. (B) The TagMap assay was used to analyze
the duplicated regions. Primers were designed within 200 bp of the break points. The two flanking regions were concatenated in reverse order (A2¡ A1 and
B2¡ B1), and the sequencing reads were aligned to verify their tandem duplication. A large proportion of the reads could be aligned to the A2–A1 junction,
indicating tandem alignment of the duplicated region in RSA-MW-3615. None of the reads aligned to the B2–B1 junction, indicating that no tandem
arrangement of the duplicated region had occurred in RSA-MW-1746. These results provide more evidence that the other copy was inserted on Chr6. (C)
Sequencing reads from the TagMap assay of RSA-MW-1746 aligned to Chr6 confirmed the insertion of an additional copy of this region from 991,188 to 991,395.
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located near the 5= end in both copies, suggesting that the duplication of this region
in RSA-MW-1746 could have been mediated by this element. In relapse isolate RSA-
MW-3615, the extra copy on chromosome six was retained as in the incident isolate, but
a tandem duplication of a larger region was observed on chromosome 1 which created
another 11 extra copies of ERG11 and the two other genes. As noted, amplification of
this small region correlated with the significant increase of FLZ resistance, and sequenc-
ing revealed the precision and efficiency of this change.
Mutations may explain virulence changes. The relative pathogenicities of the
serial isolates were experimentally compared in vivo using larvae of Galleria mellonella.
For each test, 15 larvae were infected with a comparable inoculum, and mortality was
recorded over a period of 10 days; each isolate was tested independently at least three
times (Materials and Methods) (Table S5). In 4 (22.2%) of the 18 cases, the incident and
relapse isolates significantly differed in this measure of virulence (Gehan-Breslow-
Wilcoxon test, P value  0.01). The relapse isolates from patients 1, 5, and 15 were
significantly more virulent than the corresponding incident isolates. In contrast, the
relapse isolate from patient 22 was less virulent in this assay than the incident isolate
(Fig. 4).
Examining the SNP differences between the isolates that differed in virulence
revealed that notable genes are affected. We identified an interesting SNP between the
two serial isolates of patient 5 which was located in the intron of PKR1 (CNAG_00570).
This mutation changed the acceptor site of the first intron of PKR1 in the incident
isolate from AG to CG (on the reverse strand) (Table S3); the high conservation of splice
acceptor sites in Cryptococcus (5) suggests that this change would cause a splicing error
in PKR1. Previous studies have reported that the PKR1 gene encodes the regulatory
subunit of protein kinase A (PKA) and that pkr1 mutant strains overproduce their
capsules and are hypervirulent (46, 47). Therefore, we examined capsular phenotypes
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FIG 4 Survival curves for Galleria mellonella infected with incident and relapse isolates from patients 22 (A), 1 (B), 5 (C), and 15 (D). H99 (gray) and
phosphate-buffered saline (PBS) (green) were used as positive and negative controls in the experiments. Fifteen larvae were infected per isolate, and each isolate
was evaluated three times. Mantel-Cox tests showed significant differences (P  0.01) in virulence between the incident (orange) and relapse (blue) isolates
in these samples.
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of the two paired isolates to determine if there were any phenotypic consequences of
the SNP. As displayed in Fig. 5, the incident isolate (MW-RSA-1052) with the mutation
produced substantially more capsule than the relapse isolate (MW-RSA-3156), and this
observation supports the concept of a potential dysfunction of PKR1 between these
isolates. For instance, this may suggest that the splicing site mutation in PKR1 might
lead to a defect in removing this intron and/or it may be alternatively spliced. However,
we are not clear about the mechanism for the more virulent phenotype of the smaller
capsuled relapse isolate in our in vivo test. In patient 15, we hypothesize that the
attenuated virulence of the incident isolate might also be related to the mutated BYR4.
Furthermore, this gene has been reported to be essential for viability in Schizosaccha-
romyces pombe (42, 48). In the relapse isolate from patient 1, we identified a single
nucleotide deletion causing a frameshift on CNAG_06033 and nonsynonymous substi-
tutions on CNAG_07362 (Table 2 and Table S3). However, the functions of these two
genes are yet to be determined. Finally, the relapse isolate from patient 22 had a
deletion that caused a frameshift in the RPD304 (CNAG_05690) gene. RPD304 is a class
II histone deacetylase, and the disruption of this gene has been shown to reduce
greatly the virulence of C. neoformans var. grubii in mice (28), which may explain the
attenuated virulence of this relapse isolate (Fig. 4).
Characterization of additional phenotypic changes in the serial isolates. To
investigate whether the microevolutionary genetic alterations produced phenotypic
changes besides FLZ resistance that might be related to virulence and/or host adap-
tation, we examined several other clinically relevant phenotypes: the ability to survive
and proliferate at temperatures of 37°C and 39°C or in the presence of SDS or caffeine,
which may perturb cell wall integrity, and the production of melanin, a crucial virulence
factor. We developed a high-throughput phenotypic testing method using a BM5 robot
and SGAtools (49) that can analyze up to 64 isolates on one plate (Fig. S2) (see Materials
and Methods). The results showed that some serial isolates had variable responses to
the stress conditions (Table S6). The isolates from patients 8, 15, and 81 had significant
phenotypic differences under two or more sets of conditions (Table 4). The significantly
lower resistance to SDS of the incident isolate from patient 15 may also be related to
the mutation in the BYR4 gene in it, which is essential for cell wall formation in
S. cerevisiae (50).
The relapse isolate from patient 8 has significantly higher temperature tolerance at
both 37°C and 39°C (Table 4). The genetic differences between serial isolates from
patient 8 include a large deletion region (16 kb) on chr3 of the relapse isolate
(RSA-MW-3393). Three of these six genes lost in this region have reported roles in stress
responses and pathogenesis. CNAG_02584 is a homolog of S. cerevisiae genes RRD1 and
RRD2, which are putative activators of the phosphotyrosyl phosphatase gene, PP2A.
PP2A is implicated in cell growth and signaling, and phosphorylation of PP2A is
required for the stress response in S. cerevisiae and other eukaryotes (51, 52). Moreover,
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FIG 5 (A and B) Variations in capsule size were observed between the initial isolate, MW-RSA-1052 (A), and the
relapse isolate, MW-RSA-3156 (B). Isolates were streaked onto YPD plates and grown for 3 days at 30°C, a condition
that typically results in limited capsule production. An individual colony was resuspended in PBS containing India
ink, subjected to brief vortex mixing, and examined at 63 magnification. Bars, 20 M. (C) The capsule radius for
50 cells was measured. The incident isolate had a much larger capsule size than the relapse isolate. P value,
0.0001. The cell body sizes were similar (data not shown).
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a previous study showed that deletion of RRD1 and RRD2 can enhance the resistance
of S. cerevisiae to caffeine (53). Cas33 (CNAG_02581) is involved in formation of the
cryptococcal capsule (54), the major virulence factor of pathogenic Cryptococcus spe-
cies (55). CNAG_02583 encodes a tRNA (guanine 10-N2) methyltransferase; methylation
of tRNA has been linked to protein synthesis, infections, temperature, and immune
responses in several systems (56, 57). The ARID domain protein (CNAG_02579), also in
this deleted region, was previously shown to be prematurely truncated by a frameshift
mutation in a relapse isolate (12).
In case 81, the relapse isolate had reduced growth at 39°C in comparison to its
corresponding incident isolate but produced more melanin (Table 4). Comparing the
genetic differences between these two isolates, a small indel in GCN2 (CNAG_06174)
was identified in the incident isolate (RSA-MW-913) but was reverted in the relapse
isolate (Table 2). While GCN2 is involved in responses to amino acid starvation,
intercellular acid stress, and oxidative stress response in S. cerevisiae (58–60), a melanin
synthesis-related gene, Dct, is also regulated by GCN2 (30). Thus, the difference in
melanin production may be explained by the presence of the indel in GCN2.
DISCUSSION
Microbes have developed fascinating genetic plasticity to adapt to a variety of stress
conditions within a very short time through mechanisms of microevolution. Under-
standing these processes and the magnitude of their influence on host adaptability and
drug resistance may highlight targets for new strategies and/or drugs to treat infec-
tions. However, most of the previous analyses on microevolution have been performed
with in vitro systems and animal models (5, 61). Here, the complete genome compar-
isons of clonal serial isolates from relapsing patients provided a specific window to
investigate the microevolution of Cryptococcus within the human subarachnoid space,
primarily under conditions of drug treatment. In these longitudinal samples, the
shortest time period between the collection of the incident isolate and collection of the
relapse isolate was 124 days for our paired cases, and most isolates had a much longer
exposure to the human CNS. We estimate that the mutation rate in the members of this
cohort averaged approximately one polymorphism every 58 days. This rate could have
been higher in other isolates such as those with mutations in mismatch repair genes
(SGF29 and MSH2), which have been identified in clinical isolates (62). In our study, we
identified a frameshift mutation in MLH3, which is involved in a particular class of
mismatch repair of frameshift mutations in S. cerevisiae (63), but this change did not
appear to increase the observed mutation rate.
To study the microevolution of these isolates, we compared genetic and phenotypic
changes for all the paired isolates. High-coverage whole-genome sequencing data were
obtained for each isolate, and SNP and indel calling pipelines were optimized to reduce
false positives. In parallel, we established highly reproducible assays to evaluate
clinically significant phenotypes in a large number of isolates. The combination of these
two approaches provided an efficient and reliable strategy to suggest associated
phenotypic and genetic changes.
The analyses of serial isolates from 18 patients revealed that only a few genetic
changes between incident and relapse isolates were associated with prolonged
disease. The low number of mutations is consistent with a previous report of a
single case of C. neoformans var. grubii serial isolates (64). Indeed, more than 40%
of the SNPs between serial isolates of these treated patients produced nonsynony-
mous mutations, which suggests the functional selection of genetic changes that
promoted survival and proliferation of the cryptococcal cells. This supposition was
supported by the finding that several genetic alterations in the relapse isolates led
to phenotypic changes likely to enhance host adaptation or resistance to treatment.
For example, the relapse isolate of patient 9 was found to have multiple duplica-
tions of a small genomic region carrying ERG11, the target gene of FLZ, and this
increase in gene copy number was associated with the acquisition of a dramatic
increase in resistance to FLZ. The acquisition of tandem duplications of ERG11 may
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provide drug resistance that is more stable than that of isolates that acquire
chromosome 1 aneuploidies, known to contribute to heteroresistance. A different
deletion, in patient 15, caused a frameshift mutation of the BYR4 gene in the
incident isolate, and this genetic change provides an explanation for the increased
resistance to FLZ in the relapse isolate. Among the patients in this investigation, 10
were known to have received FLZ, albeit with different regimens, and in 5 cases, the
relapse isolates had 4-fold or greater increases in FLZ MICs (Table 4).
Apart from resistance to FLZ, five other clinically relevant phenotypes were evalu-
ated and compared among the isolates. Among the other phenotypes that we com-
pared, a minority of patient isolates differed in growth at higher temperature, response
to chemical stress, or melanin production. Virulence was tested with the standard
model of infecting and quantifying the survival of wax moth larvae. The paired isolates
from four patients differed significantly in virulence; in three cases, the relapse isolate
was more lethal than the incident isolate, and in the fourth case, it was less virulent
than the incident isolate (Fig. 4). Few of the genetic alterations in these isolates were
linked to the genes that could account for these differences. However, the results are
not unexpected in that numerous studies have confirmed that cryptococcal pathoge-
nicity is polygenic and that the genes required for growth in the mammalian CNS may
not be essential for larval lethality. In the subarachnoid space, cryptococcal cells are
under constant stress. Even in the absence of mutations or genomic rearrangements,
the expression of critical genes may be regulated as needed. Nevertheless, as detailed
in Results, the paired isolates from all four cases had indels or SNPs that altered genes
reported to affect cryptococcal virulence, such as PKR1 and RPD304.
In this study, we tried to link phenotypic changes to genetic changes to reveal the
contribution of microevolution in building pathogenicity of a microorganism within the
human body. Clearly, we successfully identified some mutations that were very likely
selected for enhancement of antifungal drug resistance or other stress conditions, but
we also found that strong phenotypic changes were observed between the paired
isolates in several samples but that no or very limited genetic changes were identified.
We speculate that there are three major possible reasons for the results. First, the
genome sequencing method that we used was not able to detect the epigenetic
modifications between the serial isolates, which have been shown to affect host-
pathogen interactions in C. albicans and other pathogens (65–67). The modulation of
gene expression through histone deacetylation or nucleotide methylation has also
been implicated in affecting the fitness and pathogenicity of C. neoformans var. grubii
(68, 69). A recent comparison of closely related strains of C. gattii with different
phenotypes and genetic changes found mutations in two histone deacetylases (70).
The second reason that is the general method used in SNP calling from the next-
generation sequencing (NGS) data usually has around a 1% error rate (71, 72); conse-
quently, we applied very rigorous settings in variant calling and followed that by a
manual check to ensure the accuracy of the result. Thus, an increase in the false-
negative rate may be inevitable. Third, reference genome-based analysis may miss
genes unique to isolates from the other lineages. For example, our C. neoformans var.
grubii reference genome that we used was H99, which is a representative of the VNI
lineage, and there are two other lineages, VNII and VNB, in C. neoformans var. grubii
(73).
In all, approximately a quarter of strains changed their stress and virulence pheno-
types within 3 to 4 months of human subarachnoid space exposure. While genetic
changes of Cryptococcus occur on a real-time basis during human CNS infections,
additional work will be needed to study the impact of specific changes to more directly
link them to a phenotype. The adaptation of Cryptococcus to the host response and
treatment may further highlight genes that are critical for infection and help to
understand the dynamics of infection that are important to consider in developing new
interventions.
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MATERIALS AND METHODS
DNA isolation and sequencing. From a previous investigation of HIV/AIDS patients who relapsed
with CM (14), we selected serial isolates from 15 cases of CM caused by C. neoformans var. grubii (8 of
molecular type VNI, 2 VNB, and 5 VNI) and 3 cases due to C. gattii (1 VGI and 2 VGIV) (Table 1). From these
cases, we analyzed all 38 serial isolates (17 of molecular type VNI, 4 VNB, 11 VNII, 2 VGI, and 4 VGIV). Each
isolate was recovered from a freezer stock, thawed, streak-plated on yeast extract-peptone-dextrose
(YPD) agar, and grown at 37°C for 36 to 48 h to produce isolated colonies. A single colony was streaked
to a fresh YPD plate and grown for 24 h, a portion of the yeast cells (~100 l) was used for DNA isolation
with a MasterPure yeast DNA purification kit (Epicenter, Madison, WI) from sheared genomic DNA of each
isolate as directed by the manufacturer’s instructions, and a small insertion library was constructed and
sequenced on an Illumina HiSeq 2000 sequencer, generating between 14 and 150 million 101-bp
paired-end reads per isolate. This resulted in a 56-fold to 603-fold average depth of aligned bases
compared to C. neoformans var. grubii H99 genome or the known sequenced C. gattii genomes.
Read alignment and variant identification. Illumina reads were aligned to one of the reference
genome assemblies using Burrows-Wheeler Aligner (BWA) v0.7.4-r385 mem (76) and converted to sorted
BAM format using SAMtools v0.1.9 (r783) (77). The Genome Analysis Toolkit (GATK) v2.7-4-g6f46d11 (78)
was used to call both variant and reference nucleotides from the alignments. Briefly, the Picard tools
AddOrReplaceReadGroups, MarkDuplicates, CreateSequenceDictionary, and ReorderSam were used to pre-
process the alignments (http://broadinstitute.github.io/picard/). We then used GATK RealignerTarget-
Creator and IndelRealigner to resolve misaligned reads close to indels on serial isolate pairs to avoid
discrepancies between isolates. Next, GATK Unified Genotyper (with the haploid Genotyper ploidy
setting) was run with both SNP and indel genotype likelihood models (GLM). We also ran Base
Recalibrator and PrintReads for base quality score recalibration on those initial sites for GLM SNP and
then recalled variants with Unified Genotyper with the parameter “—output_mode EMIT_ALL_SITES.” We
merged and sorted all of the calls and then ran Variant Filtration with the parameters “QD  2.0, FS 
60.0, MQ  40.0.” Next, we removed any base that had less than a minimum genotype quality of 50, a
minimum percent alternate allele (AD) of 80%, or a minimum depth of 10. Finally, we removed any
positions that were called by both GLMs (i.e., incompatible indels and SNPs), any marked as “LowQual”
by GATK, any nested indels, and any sites that did not include a PASS flag. The final base calls covered
95% of the genome for any given isolate. We then categorized every single base between the serial
isolates and annotated those changes using the General Feature Files (GFF).
Variant Call format (VCF) files generated by GATK were compared among isolates from same patient.
All the identified SNPs between two adjacent time points in serial isolates were validated by manual
inspection of read alignments using igvtools (79). All indels located in the coding regions were also
verified manually using igvtools.
Phylogenetic analysis. In total, 503,457 positions (2.7% of the genome) were called a reference or
an SNP (i.e., nonambiguous) position in every VCF and included a variant in at least one isolate. A FASTA
file of these positions was created and converted into phylip format, and a phylogenetic tree was
generated using RAxML v7.7.8 (80) with 1,000 bootstrap replications. RAxML was run with the general-
ized time-reversible (GTR) and category (CAT) rate approximation with final evaluation of the tree using
GTR plus gamma-distributed rates.
Large genomic deletion and duplication region identification. To discover large deletions in the
genomes, we applied multiple deletion detection methods, including DELLY (version 0.0.9) (81), Break-
Dancer (version 1.1) (82), Pindel (version 0.2.4t) (83), and CNVnator (0.2.7) (84). All candidate duplication
regions were identified using CNVnator. The read realignment files generated by GATK were followed by
duplicate read removal using Picard tools and then processed using all the aforementioned software
according to the following settings. A bin size of 50 bp was used for CNVnator. All the raw calls were
filtered for the size (100 bp), call region around centromeres ( 200 bp), and repetitive sequences (50%
overlapping). The average read depth of each copy number variation (CNV) call was calculated and
compared with the average read depth of the relevant chromosome. We retained only the deletion
regions with 20% read depth and duplication regions with 180% read depth for the chromosome.
Default settings were used for DELLY, BreakDancer, and Pindel, and the following filters were set for
DELLY and BreakDancer. All raw deletion calls with quality scores of20 or supporting reads of5 were
removed from DELLY, and deletion calls with quality scores of 90 and supporting reads of 5 were
removed from the results of BreakDancer.
All the deletion calls from each of the four software methods were merged, and de novo assembly
of these regions was performed to verify the deletion calls. Briefly, Illumina reads falling into the intervals
[(START_INNER 500 bp, START_INNER 100 bp) and (END_INNER 100 bp, END_INNER 500 bp)] for
deletion calls were obtained from the bam files using SAMtools and assembled using Velvet (version
1.2.07) according to the insertion length of sequencing libraries. Next, the generated contigs were
aligned against the putative deletion regions of the corresponding genomes with 200-bp flanking
sequences using cross match (version 0.990319) (http://www.phrap.org). If pairwise alignment indicated
the existence of the deletion and if the length of the aligned contig differed by10% from the expected
length, the deletion call was accepted. Identified deletion regions were compared between the isolates
from the same patient, and variant deletions were manually checked using igvtools.
Experimental investigation of the duplication regions. Genomic DNA of RSA-MW-1746 and
RSA-MW-3615 was extracted as described above. Two primers were designed within 100 bp of the
duplication breakpoints. The primer sequences of the RSA-MW-1746 duplication region were 5=-CCATC
GTCCGTCGGAATCAGTC (left) and 5=-CTTCGAGAACACCTTGAGGACC (right), and the RSA-MW-3615
primer sequences were 5=-GAAGAAATTGGTGGATGCAAGC (left) and 5=-GCCACTCATCTCATTGTTCATC
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(right). The TagMap assay was performed as previously described (45). After removal of the adaptor
and primer sequences, all the sequence reads within 20 bp of the duplication breakpoints were
selected and aligned to the C. neoformans var. grubii H99 genome. The putative insertion region of
the extra copies needed to have both ends perfectly aligned by the reads from the two duplication
ends. To identify tandem duplication of the duplicated regions, artificial sequences were created
using the 100-bp sequences from both duplication ends and concatenated from the 3= end
sequence in 5=-to-3= order and from the 5= end sequences in 5=-to-3= order. Since the sequence reads
could be aligned to the middle of the artificial sequence, formation of the tandem duplication in the
duplication region was confirmed (Fig. 3B).
Galleria mellonella infections. The virulence of the isolates was evaluated by monitoring the
survival of infected Galleria mellonella larvae (Vanderhorst, Inc., St. Marys, OH), as previously described
(85). Healthy larvae weighing between 200 mg and 400 mg were used for each experiment. For each
isolate, an inoculum of ~50,000 cells (10 l [5  106 CFU/ml]) was injected into the larvae, and 15 to 20
larvae were used in each test. Infected larvae were placed in petri dishes and incubated at 37°C in the
dark. The number of surviving larvae was recorded daily for 10 days postinoculation. Each experiment
was repeated three times. The survival data were analyzed using the Kaplan-Meier method with
GraphPad Prism software.
Analyses of phenotypes. The recovered freezer stock of each isolate was streak-plated on YPD agar
and incubated at 37°C for 36 to 48 h. A single colony was selected and transferred to three wells across
two 96-well plates containing 200 to 300 l of YPD broth (BD Difco) and incubated for 24 to 48 h at 30C.
The colonies were then pin replicated into 384-well plates containing 80 l of YPD broth (BD Difco) and
incubated for 24 to 48 h at 30°C. The liquid culture was then transferred to rectangular agar plates
(Greiner Bio-One, catalog no. 781186) at a density of 1,536 colonies per plate using a 384-pin replicating
tool with a BM5 robot (S&P Robotics Inc., Ontario, Canada). To minimize any effect of the location of the
colonies on the plate (e.g., edge versus center or proximity of colonies), each colony from the 384-well
microplate was replicated 24 times (on separate plates [6 sets of 4 blocks]) (see Fig. S2A in the
supplemental material). Moreover, for each test, we used two technical replicates, at least three
independent tests were performed for each set of conditions (Fig. S2B), and each batch experiment
included a control testing of growth at 30°C on YPD. Images of each plate were collected using the same
conditions such as aperture and exposure time once a day over 3 days.
The images of colony growth for all testing plates were analyzed using SGATools (49, 86) (Fig. S2C)
(see below). Except for the production of melanin by the isolates on L-3,4-dihydroxyphenylalanine
(L-DOPA) plates, which was measured by colony color, the growth of each isolate under various
conditions was quantified by colony size (see Table S6 in the supplemental material). To minimize system
error caused by variations in colony size or color, we calculated averages of the values within the 25%
to 75% range for 24 replicates, and then Pearson product-moment correlation coefficients (known as r)
between two technical replicates within all the middle quadrants were calculated. Tests with an r score
of less than 0.95 were removed from further analysis, and each set of conditions was required to have
three valid independent tests (Fig. S3 and S4).
To eliminate the impact of the different growth rates of these isolates, the colony size of each isolate
after incubation at 30°C on YPD agar was deemed to represent an isolate’s basal or control rate of
growth. For example, the colony sizes of isolates under conditions of incubation at 37°C or 39°C, and in
media with SDS or caffeine, were normalized by dividing them by the corresponding colony sizes at 30°C
on YPD to obtain a relative growth rate under each stress condition. However, for melanin production,
the average colony pigment of the replicates for each isolate was normalized to the colony pigment of
the isolate at 30°C on YPD in the same experimental batch. A t test was performed to compare the results
from incident and relapse isolates from the same patient with the normalized average values from three
tests. All the data analyses and statistical tests were performed in R (87).
Cell wall integrity was assessed on 2% agar YPD medium containing 0.5 g/liter caffeine and 0.03%
SDS. Melanin was induced by the use of medium composed of 20 g/liter agar, 1 g/liter L-asparagine,
1 g/liter glucose, 3 g/liter KH2PO4, 0.25 g/liter MgSO4 · 7H2O, 1 mg/liter thiamine HCl, 5 g/liter biotin, and
100 mg/liter L-DOPA.
Data Availability. The sequencing data of 38 isolates were submitted to SRA under umbrella project
(PRJNA371609), and the project accession numbers are PRJNA227958 (RSA-MW-36), PRJNA227967
(RSA-MW-3335), PRJNA227966 (RSA-MW-1340), PRJNA227944 (RSA-MW-3393), PRJNA227950 (RSA-MW-
2799), PRJNA227941 (RSA-MW-5913), PRJNA227936 (RSA-MW-506), PRJNA227937 (RSA-MW-3877),
PRJNA227935 (RSA-MW-5465), PRJNA227943 (RSA-MW-1485), PRJNA227946 (RSA-MW-4085), PRJNA227948
(RSA-MW-628), PRJNA227955 (RSA-MW-2914), PRJNA227960 (RSA-MW-2163), PRJNA227959 (RSA-MW-3747),
PRJNA227949 (RSA-MW-2015), PRJNA227942 (RSA-MW-3474), PRJNA227951 (RSA-MW-1186), PRJNA227953
(RSA-MW-3179), PRJNA227965 (RSA-MW-913), PRJNA227940 (RSA-MW-2967), PRJNA227957 (RSA-MW-1052),
PRJNA227968 (RSA-MW-3156), PRJNA227952 (RSA-MW-1746), PRJNA227956 (RSA-MW-3615), PRJNA227934
(RSA-MW-1281), PRJNA227938 (RSA-MW-2645), PRJNA227969 (RSA-MW-852), PRJNA227954 (RSA-MW-3316),
PRJNA227970 (RSA-MW-4119), PRJNA227963 (RSA-MW-2364), PRJNA227945 (RSA-MW-3580), PRJNA227975
(RSA-MW-2399), PRJNA227972 (RSA-MW-4243), PRJNA227973 (RSA-MW-500), PRJNA227976 (RSA-MW-2343),
PRJNA227974 (RSA-MW-3980), and PRJNA227971 (RSA-MW-6610). Sequences of the nuclear genome and
General Feature Files (GFF) for C. gattii isolates VGI WM276 (74), VGIV IND107 (75), and C. neoformans var.
grubii isolate VNI H99 (5) are available at NCBI (GenBank project accession numbers GCA_000185945.1,
GCA_000835755.1, and GCA_000149245.3, respectively).
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